US 6451312
VEGF-gelonin for targeting the vasculature of solid tumors
expired A61KA61K2039/505A61K2123/00
Quick answer
US patent 6451312 (VEGF-gelonin for targeting the vasculature of solid tumors) held by The Board of Regents of the University of Texas System expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2123/00, A61K38/00, A61K47/6817